We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

158 hedge funds and large institutions have $1.02B invested in Spectrum Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 61 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 12

194% more call options, than puts

Call options by funds: $6.16M | Put options by funds: $2.09M

177% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 22

145% more capital invested

Capital invested by funds: $416M → $1.02B (+$603M)

27% more funds holding

Funds holding: 124158 (+34)

Holders
158
Holders Change
+34
Holders Change %
+27.42%
% of All Funds
3.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
47
Increased
61
Reduced
22
Closed
12
Calls
$6.16M
Puts
$2.09M
Net Calls
+$4.07M
Net Calls Change
+$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
26
Invesco
Georgia
$5.54M +$1.43M +158,354 +67%
Bank of America
27
Bank of America
North Carolina
$4.76M +$974K +107,673 +47%
Morgan Stanley
28
Morgan Stanley
New York
$4.62M +$1.4M +155,216 +90%
CAM
29
ClariVest Asset Management
California
$3.97M +$363K +40,115 +17%
SIM
30
Sonora Investment Management
Arizona
$3.78M +$266K +29,360 +12%
WG
31
Winton Group
United Kingdom
$3.26M +$2.1M +231,947 New
Barrow, Hanley, Mewhinney & Strauss
32
Barrow, Hanley, Mewhinney & Strauss
Texas
$3.26M
BIM
33
Bogle Investment Management
Massachusetts
$3.25M +$2.09M +231,132 New
Millennium Management
34
Millennium Management
New York
$3.13M +$1.27M +140,309 +171%
TCIM
35
TIAA CREF Investment Management
New York
$3.11M +$76.7K +8,477 +4%
JGC
36
J. Goldman & Co
New York
$2.6M +$1.67M +184,975 New
Fisher Asset Management
37
Fisher Asset Management
Washington
$2.52M +$1.62M +179,209 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$2.31M +$68.3K +7,550 +5%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$2.22M +$405K +44,815 +40%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$2.19M
PCM
41
Piermont Capital Management
Missouri
$2.15M -$857K -94,690 -38%
OAM
42
Oxford Asset Management
United Kingdom
$2.15M +$1.43M +157,663 New
NI
43
Numeric Investors
Massachusetts
$2.07M -$1.68M -185,447 -56%
PP
44
PDT Partners
New York
$2M
UBS Group
45
UBS Group
Switzerland
$1.97M +$427K +47,174 +51%
Legal & General Group
46
Legal & General Group
United Kingdom
$1.95M +$65.2K +7,212 +5%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.89M
Prudential Financial
48
Prudential Financial
New Jersey
$1.76M +$79.1K +8,745 +8%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.75M -$121K -13,362 -10%
AIM
50
Alambic Investment Management
California
$1.74M -$372K -41,091 -25%

SPPI Hedge Fund Activity: Q3 2017 in Review

158 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2017, worth a combined $1.02B — up 145% from $416M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new SPPI positions and 12 closed out — a net gain of 35 holders — while 61 added to existing stakes and 22 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $60.5M. The largest seller was Macquarie Group, cutting an estimated $6.95M.

  • 158 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2017, up from 124 in Q2 2017.
  • Funds reported $1.02B of Spectrum Pharmaceuticals Inc stock for Q3 2017, up 145% quarter-over-quarter.
  • 47 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2017 and 12 closed out, a net change of +35 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2017 was Consonance Capital Management, an estimated $60.5M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2017 was Macquarie Group, an estimated $6.95M sold.

Based on aggregated 13F filings for Q3 2017.